Historically, the loss of patent protection on a brand name pharmaceutical product has resulted in a 70% decline in product sales. If the patent carried on company X's balance as an intagible asset valued at 120 million, in the event of patent protection loss, how should the company refelect this in its financial statements. ( Balance sheet, income statement, cash flow ) ?